Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy.

Ramos, Rodrigo Nalio; Amano, Mariane Tami; Paes Leme, Adriana Franco; Fox, Jay Willian; de Oliveira, Ana Karina

Ramos, Rodrigo Nalio; Amano, Mariane Tami; Paes Leme, Adriana Franco; Fox, Jay Willian; de Oliveira, Ana Karina.

Afiliación

Ramos RN; Departament of Hematology and Cell Therapy, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), D'Or Institute for Research and Education (IDOR), Hospital Das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Amano MT; Hospital Sirio Libanes, São Paulo, Brazil.
Paes Leme AF; Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.
Fox JW; Department of Microbiology, Immunology and Cancer Biology, Office of Research Core Administration (ORCA), University of Virginia School of Medicine, Charlottesville, VA, United States.
de Oliveira AK; Department of Pathology, University of Virginia School of Medicine, Spatial Biology Core (SBC) Facility, Charlottesville, VA, United States.

Front Cell Dev Biol ; 10: 971275, 2022.

Article en En | MEDLINE | ID: mdl-36072339

Palabras clave

immune checkpoint blockade; immune therapeutics; prognosis; tumor immune microenvioronment; tumor stroma cross-talk; tumormicroenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google